
Eko
Supporting healthcare providers with FDA cleared AI-enabled advanced stethoscopes, high fidelity tele-auscultation, and wireless auscultation.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor investor | €0.0 | round | |
investor investor investor investor investor investor investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
* | $41.0m Valuation: $325m | Series D | |
Total Funding | 000k |
Related Content
Eko Health is a pioneering startup that specializes in advanced medical devices and software aimed at improving cardiovascular disease detection. The company offers electronic digital stethoscopes that integrate with powerful software and artificial intelligence (AI) to assist healthcare professionals in identifying heart conditions more accurately and efficiently. Eko's products are designed to serve clinicians, including doctors, nurses, and other healthcare providers, who are focused on delivering high-quality patient care.
Operating in the healthcare technology market, Eko Health combines traditional stethoscope functionality with modern digital enhancements. Their stethoscopes come equipped with features like Bluetooth connectivity, noise cancellation, and amplification, allowing clinicians to listen wirelessly and clearly. The AI-powered software automatically checks for signs of heart disease, such as atrial fibrillation (AFib) and heart murmurs, without interrupting the examination process. This automated detection boasts high sensitivity and specificity rates, ensuring reliable results.
Eko Health's business model revolves around selling these advanced stethoscopes and offering subscription-based access to their AI-driven software. This dual revenue stream ensures a steady income from both product sales and recurring software subscriptions. Additionally, Eko provides value-added services like generating and sharing medical reports easily and enabling HIPAA-compliant live streams for telemedicine exams.
The company leverages the largest dataset of real-life heart sounds to train its AI, ensuring that its detection algorithms are both accurate and reliable. By focusing on early detection and timely intervention, Eko Health aims to enhance the confidence of clinicians in diagnosing heart and lung diseases, ultimately leading to better patient outcomes.
Keywords: digital stethoscopes, AI-powered, cardiovascular detection, healthcare technology, clinicians, heart disease, telemedicine, noise cancellation, Bluetooth, automated diagnosis.